Palvella Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	518	135	-	-
Enterprise Value	447	215	-	-
Last Close Price	44.64	12.00	-	-
PB Ratio	8.85	2.15	-	-
P/TBV Ratio	10.52	2.15	-	-
Debt / Equity Ratio	0.30	0.19	-2.08	-1.40
Quick Ratio	7.53	7.14	3.11	2.78
Current Ratio	7.67	7.33	3.20	2.86
Return on Equity (ROE)	-151.15%	-59.37%	-	-
Return on Assets (ROA)	-37.25%	-18.39%	-61.63%	-
Return on Capital (ROIC)	-46.16%	-22.38%	-110.58%	-
Earnings Yield	-5.57%	-12.95%	-	-
Buyback Yield / Dilution	-19.89%	-24.08%	68.63%	-

Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q